Nine candidates from Hannover Medical School were successful in the election for the review boards of the German Research Foundation (DFG) and will review, evaluate and decide on research proposals in future.
The review board members of the German Research Foundation (DFG) are involved in funding decisions in their respective subject areas. The central task of the review boards is to ensure the quality of review and evaluation in the preparation of DFG funding decisions. This autumn, more than 50,000 researchers elected the 649 members of the 49 review boards.
Nine candidates from Hannover Medical School (MHH) were successful in the election for the term of office from 2024 to 2028:
- Professor Dr Martina de Zwaan, Director of the Department of Psychosomatics and Psychotherapy:
Review Board Neurosciences, Subject 2.23-10 Clinical Psychiatry, Psychotherapy - Professor Dr Christine Falk, Head of the Institute of Transplantation Immunology:
Review Board Microbiology, Virology, Immunology, Subject 2.21-05 Immunology - Professor Dr Frank Bengel, Director of the Clinic for Nuclear Medicine and Dean of Research at MHH:
Review Board Medicine, Subject 2.22-33 Nuclear Medicine, Radiotherapy, Radiobiology - Professor Dr Natalya Di Donato, Head of the Institute of Human Genetics:
Review Board Medicine, Subject 2.22-03 Human Genetics - Professor Dr Florian Heidel, Director of the Department of Haematology, Haemostaseology, Oncology and Stem Cell Transplantation:
Review Board Medicine, Subject 2.22-14 Haematology, Oncology - Professor Dr Theresia Kraft, Head of the Institute of Molecular and Cellular Physiology:
Review Board Medicine, Subject 2.22-04 Anatomy and Physiology - Professor Dr Dr Anette Melk, Dean of Academic Career Development and Professor of Interdisciplinary Transplantation Medicine:
Review Board Medicine, Subject 2.22-20 Paediatrics and Adolescent Medicine - Professor Dr Dr Axel Schambach, Head of the Institute of Experimental Haematology:
Review Board Medicine, Subject 2.22-14 Haematology, Oncology - Professor Dr Torsten Witte, Director of the Clinic for Rheumatology and Immunology:
Review Board Medicine, Subject 2.22-18 Rheumatology
The only time in the past 20 years that there have been as many successful candidates from the MHH as in this election was in 2011.
"Responsible task of professional quality assurance"
MHH President Professor Dr Michael Manns congratulates the new MHH members of the DFG Review Boards for Neuroscience, Microbiology and Medicine: "They are taking on a responsible task by ensuring professional quality assurance in the three-stage process of review, evaluation and decision-making. At the same time, they further develop funding practice in their specialist disciplines. I would like to express my sincere thanks to the members who are now leaving and who have represented the MHH on the DFG Review Boards over the past three years."
"The members of the review boards ensure that DFG funding decisions are made in accordance with scientific standards and in the spirit of curiosity, innovation and a thirst for knowledge," says DFG President Professor Dr Katja Becker. "At the same time, the voluntary commitment.”
Text: Inka Burow